CommentMeeting the unmet need for family planning: now is the time
References (10)
- et al.
The rebirth of family planning
Lancet
(2012) - et al.
Use of human rights to meet the unmet need for family planning
Lancet
(2012) - et al.
National, regional, and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: a systematic and comprehensive analysis
Lancet
(2013) - et al.
Trends in contraceptive need and use in developing countries in 2003, 2008, and 2012: an analysis of national surveys
Lancet
(2013) - et al.
Maternal deaths averted by contraceptive use: an analysis of 172 countries
Lancet
(2012)
Cited by (28)
Reviving permanent contraception: New medical procedures or new service delivery modalities?
2020, Best Practice and Research: Clinical Obstetrics and GynaecologyCitation Excerpt :Both supply-side and demand-side components functioning in an enabling environment for service delivery that ensures informed choice and respects rights [31], Fig. 1. In consequence, innovations should happen at all levels; encompassing not only the development of new occlusion technologies, but also the use of novel implementation processes that increase availability and access to family planning, including permanent methods [32]. Fostering an environment that enables the delivery of permanent contraception is a crucial element in any effort to increase access to family planning.
Male hormonal contraception: hope and promise
2017, The Lancet Diabetes and EndocrinologyCitation Excerpt :These desires are constrained by the need to space out and limit pregnancies according to personal and financial circumstances. Enabling men and women to share family planning responsibilities by increasing contraceptive choices would promote important, but still mostly unmet, individual and societal needs such as reducing overpopulation and the number of elective terminations for unplanned pregnancies.1 Promising candidate non-hormonal male-directed approaches have been identified,2,3 but clinical trials in human beings, which would be necessary for drug or device registration, have not been done (table 1).
Polidocanol induced tubal occlusion in nonhuman primates: immunohistochemical detection of collagen I-V
2016, ContraceptionCitation Excerpt :There remains an unmet need for effective contraception worldwide. In developing countries, greater than 24% of married women wanting contraception lack modern methods [1]. A shift away from sterilization, the most effective method, toward reversible methods, appears to have contributed to increases in unintended pregnancies in countries with limited resources [2].
Acceptability of the nestorone®/ethinyl estradiol contraceptive vaginal ring: Development of a model; implications for introduction
2014, ContraceptionCitation Excerpt :These design features suggest the NES/EE CVR can address common family planning access and service delivery issues that are especially pronounced in low resource settings. It has the potential to be an important new method in regions with a high unmet need for contraception [3–6]. Acceptability research, however, must be conducted to understand aspects of use affecting utilization and is an integral component of planning for introduction [7–11].
Global family planning metrics - Time for new definitions?
2014, Contraception